12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Metaxalone SoluMatrix tablets: Completed Phase I enrollment

iCeutica completed enrollment of an undisclosed number of healthy volunteers in a U.S. Phase I trial comparing Metaxalone SoluMatrix tablets vs. Skelaxin metaxalone from Pfizer Inc....

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >